For drug and device companies, a product recall is bad. Dealing with multiple recalls at the same time is worse. Trying to manage either scenario without a plan is nightmare territory. That’s what ExpertRECALL wanted to illustrate during a mock recall held last month in Indianapolis. The company devoted a half-day of the Bio/Pharmaceutical and […]
A Purdue University startup thinks it has a solution for the challenge of getting soft tissue to bond with hard bone. BioRegeneration Technologies co-founders Darryl Dickerson and Eric Nauman say InMotion has the potential to be a one-time-only, permanent solution for joint pain and degeneration. InMotion is a porous scaffolding made of a nonbiodegradable, collagen-based […]
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
There’s a lot of money at stake when pharmaceutical companies are developing a drug with blockbuster potential. MedeoLinx Inc. wants to improve the odds. The Indianapolis bioanalytical CRO says its informaticians and medical scientists can accurately predict a drug’s potential and likely success in the approval process, said Dr. Jake Chen, company founder. Pharmaceutical companies […]
Diagnotes Inc. wants to make it easier for on-call doctors to get up to speed quickly with patients they may have never met. The Indianapolis startup is on the verge of launching a two-part strategy to enable on-call clinicians and physicians to provide care faster and to ensure the patient gets proper follow-up care. Diagnotes […]